Vivo Capital, LLC Portfolio Holdings

Vivo Capital, LLC

  • $683 Million
  • Q3 2024

Vivo Capital, LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $683 Million distributed in 43 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Geron Corp with a value of $124M, Harmony Biosciences Holdings, Inc. with a value of $104M, Verona Pharma PLC with a value of $102M, Terns Pharmaceuticals, Inc. with a value of $57.5M, and Dyne Therapeutics, Inc. with a value of $40M.

Examining the 13F form we can see an increase of $6.31M in the current position value, from $677M to 683M.

Vivo Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Vivo Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $683 Million
Healthcare: $683 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.32B
$124 Million 18.09% of portfolio
27,225,292
Q1 2024 Added 12.76%
$2.03B
$104 Million 15.24% of portfolio
2,606,247
Q4 2022 Reduced 23.35%
$2.56B
$102 Million 14.95% of portfolio
3,549,758
Q2 2024 Reduced 1.67%
$220M
$57.5 Million 8.42% of portfolio
6,895,746
Q3 2024 Added 11.53%
$1.24B
$40 Million 5.86% of portfolio
1,114,960
Q3 2024 Reduced 31.81%
$759M
$38.2 Million 5.59% of portfolio
1,678,207
Q4 2022 Added 1.1%
$247M
$20.1 Million 2.94% of portfolio
1,105,454
Q1 2024 Added 116.67%
$310M
$18.4 Million 2.7% of portfolio
6,756,756
Q2 2024 New
$247M
$18 Million 2.63% of portfolio
1,505,862
Q3 2024 Reduced 19.63%
$145M
$17.1 Million 2.5% of portfolio
1,552,685
Q3 2024 Reduced 33.33%
$363M
$13.7 Million 2.01% of portfolio
1,608,000
Q3 2023 New
$166M
$13.6 Million 1.99% of portfolio
2,797,704
Q1 2024 Reduced 13.73%
$325M
$13.1 Million 1.92% of portfolio
1,277,818
Q3 2024 Added 0.64%
$241M
$12.9 Million 1.88% of portfolio
1,650,440
Q4 2023 Reduced 11.08%
$516M
$12.1 Million 1.77% of portfolio
1,122,471
Q3 2024 Reduced 50.0%
$33.9M
$11.6 Million 1.7% of portfolio
1,842,751
Q2 2024 New
$94.7M
$9 Million 1.32% of portfolio
997,005
Q3 2024 Reduced 40.18%
$232M
$7.91 Million 1.16% of portfolio
1,497,268
Q3 2024 New
$23.3M
$7.85 Million 1.15% of portfolio
5,000,000
Q1 2024 New
$66M
$7.34 Million 1.07% of portfolio
4,034,522
Q3 2024 Reduced 4.4%
$140M
$6.54 Million 0.96% of portfolio
3,556,023
Q1 2023 Reduced 0.05%
$22.2M
$6.48 Million 0.95% of portfolio
6,173,439
Q3 2023 Added 104.72%
$236M
$5.39 Million 0.79% of portfolio
1,612,903
Q3 2024 New
$18.8M
$2.29 Million 0.33% of portfolio
3,521,291
Q4 2023 Reduced 9.04%
$102M
$1.92 Million 0.28% of portfolio
2,956,110
Q3 2024 Reduced 1.07%
$10.2M
$1.83 Million 0.27% of portfolio
4,470,152
Q3 2024 Added 28.82%
$346M
$1.2 Million 0.17% of portfolio
388,144
Q4 2020 Reduced 73.71%
Verastem Inc
-
$0 0.0% of portfolio
-
Q2 2023 New
Sinovac Biotech Ltd.
-
$0 0.0% of portfolio
-
Q1 2024 New
Tourmaline Bio Inc.
-
$0 0.0% of portfolio
-
Q4 2023 New
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Tenax Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 14.01%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q3 2024 New
Engene Holdings Inc.
-
$0 0.0% of portfolio
-
Q4 2023 New
Q32 Bio Inc.
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 94.44%
Precision Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Adverum Biotechnologies, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 Reduced 44.44%
Instil Bio Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 0.0%
Corbus Pharmaceuticals Holdings
-
$0 0.0% of portfolio
-
Q2 2024 New
Dbv Technologies Sa
-
$0 0.0% of portfolio
-
Q2 2024 New
Zenas Biopharma Inc
-
$0 0.0% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 43
  • Current Value $683 Million
  • Prior Value $677 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 6 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email